Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 1/20 | 0.59 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | SCN4A | P35499 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.44 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 2/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | CPA1 | P15085 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL59840 | 1.00 | GABBR2 (0.59) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| SCHEMBL288753 | 1.00 | GABBR2 (0.59) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| Hydrochloric Acid SCHEMBL3874351 | 0.98 | GABBR2 (0.57) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| Hydrochloric Acid SCHEMBL4150999 | 0.98 | GABBR2 (0.57) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| SCHEMBL9386161 | 0.98 | GABBR2 (0.57) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| Hydrochloric Acid SCHEMBL2934796 | 0.98 | GABBR2 (0.57) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| Acetamide SCHEMBL27677566 | 0.92 | GABBR2 (0.52) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| SCHEMBL7244087 | 0.90 | GABBR2 (0.55) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| SCHEMBL5846637 | 0.89 | KMT2A (0.49) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| SCHEMBL5845485 | 0.89 | KMT2A (0.49) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 413 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113880721-B | Synthesis method of dapoxetine | 湖南九典制药股份有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-114057917-A | Post-treatment ashless dispersant and preparation method thereof | 中国石油天然气股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-113880721-A | Synthetic method of dapoxetine | 湖南九典制药股份有限公司 | 2022-01-04 | — | — | CN | claimed |
| CN-107935868-A | A kind of crystal form of 5 hydroxytryptamine reuptake inhibithors and preparation method thereof | 广州白云山医药集团股份有限公司白云山制药总厂 | 2018-04-20 | — | — | CN | claimed |
| CN-103664660-B | A kind of synthetic method of dapoxetine hydrochloride | SUZHOU UUGENE BIOPHARMA CO., LTD. (CN) | 2015-09-09 | — | — | CN | claimed |
| CN-103664660-A | Synthesis method of dapoxetine hydrochloride | SUZHOU UUGENE BIOPHARMA CO LTD | 2014-03-26 | — | — | CN | claimed |
| US-7015348-B2 | Method for producing an optically active β-amino acid | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-03-21 | — | — | US | claimed |
| EP-0089886-A1 | Process for the preparation of a free alpha-L-amino acid | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1983-09-28 | — | — | EP | claimed |
| EP-4591934-A2 | VARIANTS OF C-TYPE NATRIURETIC PEPTIDE | BioMarin Pharmaceutical Inc. (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-4523749-A2 | VARIANTS OF C-TYPE NATRIURETIC PEPTIDE | BioMarin Pharmaceutical Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| CN-109790114-B | Novel chiral ligand, metal chelate, various unnatural amino acids and synthesis method of maraviroc and key intermediate thereof | 中国科学院上海药物研究所 | 2025-03-07 | — | — | CN | disclosed |
| CN-109790114-B | Novel chiral ligand, metal chelate, various unnatural amino acids and synthesis method of maraviroc and key intermediate thereof | 中国科学院上海药物研究所 | 2025-03-07 | — | — | CN | disclosed |
| US-12214015-B2 | Use of c-type natriuretic peptide variants to treat osteoarthritis | BIOMARIN PHARMACEUTICAL INC. (US) | 2025-02-04 | — | — | US | disclosed |
| CN-118307428-B | Chiral alpha unnatural amino acid and preparation method thereof by rare noble metal complex | 北京元延医药科技股份有限公司 | 2025-01-10 | — | — | CN | disclosed |
| EP-0125299-A1 | GLYCOSYLATED INSULIN DERIVATIVES. | UNIV UTAH (US) | 1984-11-21 | — | — | EP | disclosed |
| US-4483792-A | SUCCINYL AND GUTARYL GLUCOSAMINES, LOWER BLOOD SUGAR | UNIVERSITY OF UTAH | 1984-11-20 | — | — | US | disclosed |
| US-4478830-A | HYPOGLYCEMIC AGENTS | UNIVERSITY OF UTAH | 1984-10-23 | — | — | US | disclosed |
| US-4478746-A | Glycosylated insulin derivatives | UNIVERSITY OF UTAH | 1984-10-23 | — | — | US | disclosed |
| WO-1984001896-A1 | GLYCOSYLATED INSULIN DERIVATIVES | UNIV UTAH (US) | 1984-05-24 | — | — | WO | disclosed |
| US-4444683-A | Glycosylated insulin derivatives | UNIVERSITY OF UTAH (US) | 1984-04-24 | — | — | US | disclosed |